Navigation Links
Merck scientist Daria Hazuda presents Bernard Fields Lecture at 20th Conference on Retroviruses and Opportunistic Infections (CROI)
Date:3/4/2013

ATLANTA, March 4, 2013 Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced its worldwide head of Antiviral Basic Research and internationally renowned scientist, Daria Hazuda, Ph.D., presented the annual Bernard Fields Lecture yesterday at the opening session of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta, Georgia. The Bernard Fields Lecture is presented annually at the opening session of CROI and features a basic research scientist who has made important and timely contributions to virology and/or viral pathogenesis as exemplified by the career of Bernard Fields. The Fields lecture by Dr. Hazuda, titled 'Antiretroviral Drug Discovery: HIV-1 Integrase Inhibitors and Beyond' is available on the CROI website.

"The presentation of the Fields' lecture represents fitting recognition of Daria's personal accomplishments and of her teams' contributions to HIV research over the past 20 years," said Peter S. Kim, Ph.D., president, Merck Research Laboratories. "Commitment to scientific excellence and devotion to improving health remains a focus for us all at Merck."

Dr. Hazuda is recognized for her pioneering work in deciphering the basic biochemistry of the HIV integrase. In her current role, Dr. Hazuda leads Merck's efforts in the discovery of novel anti-infective agents targeting HIV, hepatitis C and antimicrobial targets. Notable research that Dr. Hazuda and Merck have been involved in recently include progress made in collaboration with leading academic scientists on improving the understanding of HIV latency and developing new ways to displace dormant virus from infected cells.


'/>"/>

Contact: Caroline Lappetito
caroline_lappetito@merck.com
267-305-7639
Merck & Co., Inc.
Source:Eurekalert

Page: 1

Related medicine news :

1. Merck and Regenstrief Institute establish evidence-based care collaboration
2. Scientists solving the mystery of human consciousness
3. Scientists uncover multiple faces of deadly breast cancer
4. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
5. Scientists identify major source of cells defense against oxidative stress
6. Scientists tailor cell surface targeting system to hit organelle ZIP codes
7. Scientists rewrite rulebook on breast cancer in landmark global study
8. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
9. Warwick scientists uncover how checkpoint proteins bind chromosomes
10. NIH scientists link quickly spreading gene to Asian MRSA epidemic
11. Joslin scientists identify important mechanism that affects the aging process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Vitenas Cosmetic Surgery has been named as ... the American Institute of Architects and the Academy of Architecture for Health. The building, ... Harrell Architects, opened to patients in October of 2014. , The ...
(Date:5/5/2016)... , ... May 05, 2016 , ... TIME for Kids ... – today announced a new partnership to reach nearly 1 million children with important ... an instant and is the leading cause of accidental death in children one to ...
(Date:5/5/2016)... ... May 05, 2016 , ... In order to increase ... patterns, Amerec, a Seattle-based steam bath and sauna manufacturer recently launched amerecConnect™ ... interface of the app, developed for both smartphones and personal computers perfectly emulates ...
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs (TTL) is ... eve of National Nurses Week (May 6-12). Currently, HireNurses is a job ... enrollment into the Talent Tech Lab Virtual Incubation program, they will dramatically expand the ...
(Date:5/5/2016)... ... ... Chronic stress can have a silent, yet dangerous, impact on men’s heart health. ... inflammation, both of which raise the risk of heart attack and even stroke,” says ... Massachusetts General Hospital. Chronic stress also can lead to other issues that indirectly affect ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Israel , May 4, 2016 ... today that BiondVax,s CEO, Dr. Ron Babecoff , will ... New York City . On Thursday, ... Pioneers 2016, a conference presented by Joseph Gunner ... The BiondVax presentation that Dr. Babecoff will be ...
(Date:5/4/2016)... Yissum Research Development Company of the ... had signed an exclusive world-wide licensing and research agreement ... degradation and immunomodulatory drugs for cancer and immune dysfunction, ... first-in-class therapy for hematologic and solid malignancies. Financial terms ... novel technology was developed by Yinon Ben-Neriah , ...
(Date:5/4/2016)... 4, 2016 Valeritas Holdings, Inc. ... alternative public offering (APO). This was accomplished via a ... Inc. and a private placement of approximately 5 million ... share. Under the terms of the reverse ... Holdings, Inc. will trade on the OTC Markets under ...
Breaking Medicine Technology: